Skip to main content

Table 4 Functional enrichment of KEGG pathways for part of DNB

From: Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers

Term

Description

Genes

p-value

hsa04640

Hematopoietic cell lineage

CD3G, CD8A, CD3D, CD3E, IL7R, FLT3LG, CD1D, IL4R, MS4A1, CD2, CD5, CD14, HLA-DRA

3.23E-11

hsa04060

Cytokine-cytokine receptor interaction

IFNAR2, TNFRSF1B, IL2RB, TNFSF10, IL18RAP, CCR5, IL4R, CCR1, TGFBR2, CXCR1, IL7R, CD27, IL17RA, FLT3LG

3.87E-07

hsa04210

Apoptosis

TNFSF10, NTRK1, RIPK1, FADD, CAPN2, PIK3R2

3.82E-04

hsa05220

Chronic myeloid leukemia

BCR, TGFBR2, ABL1, CRK, PIK3R2

0.005920

hsa04010

MAPK signaling pathway

DUSP4, RASGRP1, NTRK1, MAP3K1, TGFBR2, CRK, CD14

0.043672

hsa04151

PI3K-Akt signaling pathway

FGFR2, IFNAR2, IL2RB, CD19, IL4R, RXRA, ITGB7, PIK3CD, RAC1, JAK3, IL7R, PIK3R2

0.059021